Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Structural Heart Disease Treatment Devices Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Structural Heart Disease Treatment Devices Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Repair Devices
      • 1.3.3 Replacement Devices
    • 1.4 Market Segment by Application
      • 1.4.1 Global Structural Heart Disease Treatment Devices Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Ambulatory Surgery Centers
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Structural Heart Disease Treatment Devices Production Value 2014-2025
      • 2.1.2 Global Structural Heart Disease Treatment Devices Production 2014-2025
      • 2.1.3 Global Structural Heart Disease Treatment Devices Capacity 2014-2025
      • 2.1.4 Global Structural Heart Disease Treatment Devices Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Structural Heart Disease Treatment Devices Market Size CAGR of Key Regions
      • 2.2.2 Global Structural Heart Disease Treatment Devices Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Structural Heart Disease Treatment Devices Capacity by Manufacturers
      • 3.1.2 Global Structural Heart Disease Treatment Devices Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Structural Heart Disease Treatment Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Structural Heart Disease Treatment Devices Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Structural Heart Disease Treatment Devices Market Concentration Ratio (CR5 and HHI)
    • 3.3 Structural Heart Disease Treatment Devices Price by Manufacturers
    • 3.4 Key Manufacturers Structural Heart Disease Treatment Devices Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Structural Heart Disease Treatment Devices Market
    • 3.6 Key Manufacturers Structural Heart Disease Treatment Devices Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Repair Devices Production and Production Value (2014-2019)
      • 4.1.2 Replacement Devices Production and Production Value (2014-2019)
    • 4.2 Global Structural Heart Disease Treatment Devices Production Market Share by Type
    • 4.3 Global Structural Heart Disease Treatment Devices Production Value Market Share by Type
    • 4.4 Structural Heart Disease Treatment Devices Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Structural Heart Disease Treatment Devices Consumption by Application

    6 Production by Regions

    • 6.1 Global Structural Heart Disease Treatment Devices Production (History Data) by Regions 2014-2019
    • 6.2 Global Structural Heart Disease Treatment Devices Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Structural Heart Disease Treatment Devices Production Growth Rate 2014-2019
      • 6.3.2 United States Structural Heart Disease Treatment Devices Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Structural Heart Disease Treatment Devices Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Structural Heart Disease Treatment Devices Production Growth Rate 2014-2019
      • 6.4.2 European Union Structural Heart Disease Treatment Devices Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Structural Heart Disease Treatment Devices Import & Export
    • 6.5 China
      • 6.5.1 China Structural Heart Disease Treatment Devices Production Growth Rate 2014-2019
      • 6.5.2 China Structural Heart Disease Treatment Devices Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Structural Heart Disease Treatment Devices Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Structural Heart Disease Treatment Devices Consumption by Regions

    • 7.1 Global Structural Heart Disease Treatment Devices Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Structural Heart Disease Treatment Devices Consumption by Type
      • 7.2.2 United States Structural Heart Disease Treatment Devices Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Structural Heart Disease Treatment Devices Consumption by Type
      • 7.3.2 European Union Structural Heart Disease Treatment Devices Consumption by Application
    • 7.4 China
      • 7.4.1 China Structural Heart Disease Treatment Devices Consumption by Type
      • 7.4.2 China Structural Heart Disease Treatment Devices Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Structural Heart Disease Treatment Devices Consumption by Type
      • 7.5.2 Rest of World Structural Heart Disease Treatment Devices Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Abbott
      • 8.1.1 Abbott Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Structural Heart Disease Treatment Devices
      • 8.1.4 Structural Heart Disease Treatment Devices Product Introduction
      • 8.1.5 Abbott Recent Development
    • 8.2 Boston Scientific
      • 8.2.1 Boston Scientific Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Structural Heart Disease Treatment Devices
      • 8.2.4 Structural Heart Disease Treatment Devices Product Introduction
      • 8.2.5 Boston Scientific Recent Development
    • 8.3 Edwards Lifesciences
      • 8.3.1 Edwards Lifesciences Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Structural Heart Disease Treatment Devices
      • 8.3.4 Structural Heart Disease Treatment Devices Product Introduction
      • 8.3.5 Edwards Lifesciences Recent Development
    • 8.4 LivaNova
      • 8.4.1 LivaNova Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Structural Heart Disease Treatment Devices
      • 8.4.4 Structural Heart Disease Treatment Devices Product Introduction
      • 8.4.5 LivaNova Recent Development
    • 8.5 Lepu Medical Technology
      • 8.5.1 Lepu Medical Technology Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Structural Heart Disease Treatment Devices
      • 8.5.4 Structural Heart Disease Treatment Devices Product Introduction
      • 8.5.5 Lepu Medical Technology Recent Development
    • 8.6 Medtronic
      • 8.6.1 Medtronic Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Structural Heart Disease Treatment Devices
      • 8.6.4 Structural Heart Disease Treatment Devices Product Introduction
      • 8.6.5 Medtronic Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Structural Heart Disease Treatment Devices Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Structural Heart Disease Treatment Devices Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Structural Heart Disease Treatment Devices Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Structural Heart Disease Treatment Devices Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Structural Heart Disease Treatment Devices Production Forecast by Type
      • 9.7.2 Global Structural Heart Disease Treatment Devices Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Structural Heart Disease Treatment Devices Sales Channels
      • 10.2.2 Structural Heart Disease Treatment Devices Distributors
    • 10.3 Structural Heart Disease Treatment Devices Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Structural heart disease treatment devices are repair and replacement devices used for the treatment of structural heart diseases that could lead to a heart attack, or any other issue occurring in the valves or vessels of the heart.
      North Americas accounted for the maximum growth of the cardiovascular devices market during 2017. With the growing preference for tissue heart valves over mechanical heart valves and the increased popularity of MI and transcatheter procedures in the developed economies such as the US, this region will account for the maximum growth of this market during the next few years as well.
      In 2019, the market size of Structural Heart Disease Treatment Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Structural Heart Disease Treatment Devices.

      This report studies the global market size of Structural Heart Disease Treatment Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Structural Heart Disease Treatment Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Abbott
      Boston Scientific
      Edwards Lifesciences
      LivaNova
      Lepu Medical Technology
      Medtronic
      ...

      Market Segment by Product Type
      Repair Devices
      Replacement Devices

      Market Segment by Application
      Hospital
      Ambulatory Surgery Centers
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Structural Heart Disease Treatment Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Structural Heart Disease Treatment Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Structural Heart Disease Treatment Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now